Literature DB >> 16619479

Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients.

Megumi Yanokura1, Kouji Banno, Nobuyuki Susumu, Makiko Kawaguchi, Yoshiko Kuwabara, Kastumi Tsukazaki, Daisuke Aoki.   

Abstract

BACKGROUND: p16 has been reported to disappear by hypermethylation in various cancers. However, the relationship between the frequency of hypermethylation of p16 and the mechanism of its inactivation has not been completely elucidated in endometrial cancer.
MATERIALS AND METHODS: Hypermethylation in the promoter region of the p16 gene and the expression of the p16 protein in 51 specimens, including 8 endometrial cancer cell lines, 7 normal endometrial tissues, 12 atypical endometrial hyperplasia tissues and 32 endometrial cancer tissues were analyzed.
RESULTS: Five out of 8 endometrial cancer cell lines showed hypermethylation with high frequency, although only 1 showed loss of gene expression. However, no endometrial cancer tissue of the 32 specimens showed hypermethylation. Furthermore, loss of expression was immunohistochemically observed in 3 out of the 20 specimens.
CONCLUSION: These results suggest that hypermethylation of p16 rarely occurs and, thus, has no significant effect on the carcinogenesis of endometrial cancer in Japanese patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16619479

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Aberrant promoter hypermethylation of p16 gene in endometrial carcinoma.

Authors:  Zhuo-ying Hu; Liang-dan Tang; Qin Zhou; Lin Xiao; Yi Cao
Journal:  Tumour Biol       Date:  2015-01-17

2.  A genome-wide association study identifies genetic variants in the CDKN2BAS locus associated with endometriosis in Japanese.

Authors:  Satoko Uno; Hitoshi Zembutsu; Akira Hirasawa; Atsushi Takahashi; Michiaki Kubo; Tomoko Akahane; Daisuke Aoki; Naoyuki Kamatani; Koichi Hirata; Yusuke Nakamura
Journal:  Nat Genet       Date:  2010-07-04       Impact factor: 38.330

3.  Epimutations, inheritance and causes of aberrant DNA methylation in cancer.

Authors:  David Mossman; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2006-05-15       Impact factor: 2.857

4.  Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer.

Authors:  Megumi Yanokura; Kouji Banno; Masataka Adachi; Daisuke Aoki; Kuniya Abe
Journal:  Int J Oncol       Date:  2017-04-19       Impact factor: 5.650

5.  MicroRNA‑34b expression enhances chemosensitivity of endometrial cancer cells to paclitaxel.

Authors:  Megumi Yanokura; Kouji Banno; Daisuke Aoki
Journal:  Int J Oncol       Date:  2020-09-23       Impact factor: 5.650

Review 6.  Research Progress of DNA Methylation in Endometrial Cancer.

Authors:  Ting Xu; Hongmei Ding; Jie Chen; Jiahui Lei; Meng Zhao; Bingyu Ji; Youguo Chen; Songbing Qin; Qinqin Gao
Journal:  Biomolecules       Date:  2022-07-04

7.  Insights into Assessing the Genetics of Endometriosis.

Authors:  Nilufer Rahmioglu; Stacey A Missmer; Grant W Montgomery; Krina T Zondervan
Journal:  Curr Obstet Gynecol Rep       Date:  2012-06-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.